CleanSpace Holdings Limited engages in the design, manufacture, and sale of respirators and related products and services for healthcare and industrial employers worldwide.
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$1.38|
|52 Week High||AU$1.30|
|52 Week Low||AU$7.69|
|1 Month Change||0.36%|
|3 Month Change||-16.36%|
|1 Year Change||n/a|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-81.40%|
Recent News & Updates
Some CleanSpace Holdings Limited (ASX:CSX) Analysts Just Made A Major Cut To Next Year's Estimates
The latest analyst coverage could presage a bad day for CleanSpace Holdings Limited ( ASX:CSX ), with the analysts...
|CSX||AU Medical Equipment||AU Market|
Return vs Industry: Insufficient data to determine how CSX performed against the Australian Medical Equipment industry.
Return vs Market: Insufficient data to determine how CSX performed against the Australian Market.
Stable Share Price: CSX is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: CSX's weekly volatility (8%) has been stable over the past year.
About the Company
CleanSpace Holdings Limited engages in the design, manufacture, and sale of respirators and related products and services for healthcare and industrial employers worldwide. It offers CleanSpace HALO, a personal respiratory protection for healthcare; CleanSpace ULTRA, a personal respiratory protection for face/eye protection and water tolerance; CleanSpace2, a personal respiratory protection for workers in general industrial environments; and CleanSpace EX for personal protection for people working in explosive environments. The company also provides accessories and consumable products comprising masks, filters, docking stations, cleaning and storage products, car charger, biohoods, half mask and bio mask exhalation adaptors, unit id panels, mask id badges, mask decal, helmet hook strap, hoods, backpacks, full face mask quantitative fit test, full face mask spectacle kit, visor protectors, head harness, grommet, and spares.
CleanSpace Holdings Fundamentals Summary
|CSX fundamental statistics|
Is CSX overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|CSX income statement (TTM)|
|Cost of Revenue||AU$11.54m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||0.15|
|Net Profit Margin||22.81%|
How did CSX perform over the long term?See historical performance and comparison
Is CleanSpace Holdings undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate CSX's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate CSX's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: CSX is good value based on its PE Ratio (9.3x) compared to the Australian Medical Equipment industry average (13.3x).
PE vs Market: CSX is good value based on its PE Ratio (9.3x) compared to the Australian market (19x).
Price to Earnings Growth Ratio
PEG Ratio: CSX's earnings are forecast to decline next year, so we can't calculate its PEG ratio.
Price to Book Ratio
PB vs Industry: CSX is good value based on its PB Ratio (2.6x) compared to the AU Medical Equipment industry average (4.5x).
How is CleanSpace Holdings forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CSX's earnings are forecast to decline over the next 3 years (-61.5% per year).
Earnings vs Market: CSX's earnings are forecast to decline over the next 3 years (-61.5% per year).
High Growth Earnings: CSX's earnings are forecast to decline over the next 3 years.
Revenue vs Market: CSX's revenue is expected to decline over the next 3 years (-16.1% per year).
High Growth Revenue: CSX's revenue is forecast to decline over the next 3 years (-16.1% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CSX is forecast to be unprofitable in 3 years.
How has CleanSpace Holdings performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CSX has high quality earnings.
Growing Profit Margin: CSX's current net profit margins (22.8%) are higher than last year (20.8%).
Past Earnings Growth Analysis
Earnings Trend: CSX's earnings have grown significantly by 57.8% per year over the past 5 years.
Accelerating Growth: CSX's earnings growth over the past year (92.3%) exceeds its 5-year average (57.8% per year).
Earnings vs Industry: CSX earnings growth over the past year (92.3%) exceeded the Medical Equipment industry 74.9%.
Return on Equity
High ROE: CSX's Return on Equity (28%) is considered high.
How is CleanSpace Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: CSX's short term assets (A$45.8M) exceed its short term liabilities (A$7.9M).
Long Term Liabilities: CSX's short term assets (A$45.8M) exceed its long term liabilities (A$2.1M).
Debt to Equity History and Analysis
Debt Level: CSX's debt to equity ratio (5.8%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if CSX's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: CSX's debt is well covered by operating cash flow (567.1%).
Interest Coverage: CSX's interest payments on its debt are well covered by EBIT (237.5x coverage).
What is CleanSpace Holdings's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate CSX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate CSX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if CSX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CSX's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of CSX's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.
How experienced are the management team and are they aligned to shareholders interests?
CleanSpace Holdings has no CEO, or we have no data on them.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: CSX only recently listed within the past 12 months.
CleanSpace Holdings Limited's employee growth, exchange listings and data sources
- Name: CleanSpace Holdings Limited
- Ticker: CSX
- Exchange: ASX
- Founded: 2009
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: AU$106.287m
- Shares outstanding: 77.02m
- Website: https://www.cleanspacetechnology.com
- CleanSpace Holdings Limited
- Unit 5
- 39 Herbert Street
- St Leonards
- New South Wales
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/25 08:05|
|End of Day Share Price||2021/09/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.